References
- Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerg Microbes Infect. 2022;11(1):1768–1777.
- Wenham C, Eccleston-Turner M. Monkeypox as a PHEIC: implications for global health governance. Lancet. 2022 Dec 17;1400(10369):2169–2171.
- Organization WH. Monkeypox Outbreak Global [map]. 2022. Available from: https://worldhealthorg.shinyapps.io/mpx_global/
- Chiu KH, Wong SC, Tam AR, et al. The first case of monkeypox in Hong Kong presenting as infectious mononucleosis-like syndrome. Emerg Microbes Infect. 2023;12(1):2146910
- Zhao H, Wang W. The first imported case of monkeypox in the mainland of China – Chongqing Municipality, People’s Republic of China. China CDC Wkly [Internet]. 2022 Sep 16; 4(38): 853–854.
- Fine PE, Jezek Z. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17(3):643–650.
- Jang YR, Lee M. The first case of monkeypox in the Republic of Korea. J Korean Med Sci. 2022;37(27):e224.
- Ropp SL, Jin Q. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol. 1995;33(8):2069–e276.
- Damaso CR, Esposito JJ. An emergent poxvirus from humans and cattle in Rio de Janeiro State: cantagalo virus may derive from Brazilian smallpox vaccine. Virology. 2000;277(2):439–449.
- Joana Isidro1 VB. First draft genome sequence of Monkeypox virus associated with the suspected multi-country outbreak (confirmed case in Portugal). 2022 May. Available from: https://virological.org/t/first-draft-genome-sequence-of-monkeypox-virus-associated-with-the-suspected-multi-country-outbreak-may-2022-confirmed-case-in-portugal/799.
- Isidro J, Borges V. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022;28(8):1569–1572.
- Sanjuán R, Domingo-Calap P. Mechanisms of viral mutation. Cell Mol Life Sci. 2016;73(23):4433–4448.
- Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593–597.
- Burki T. Investigating monkeypox. Lancet. 2022;399(10343):2254–2255.
- Kumar N, Acharya A, Gendelman HE. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022;131:102855.
- Shchelkunov SN, Totmenin AV. Analysis of the monkeypox virus genome. Virology. 2002;297(2):172–102194.
- Johnston SC. Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol. 2015;63:42–45.
- Lum FM, Torres-Ruesta A. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597–613.
- Mack TM, Noble J, Thomas DB. A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg. 1972;21(2):214–218.
- Earl PL, Americo JL. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004;428(6979):182–185.
- Fang Q, Yang L, Zhu W, et al. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain. Virology. 2005;335(2):242–251.
- Saijo M, Ami Y, Yuriko S, et al. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol. 2006;80(11):5179–51788.
- Golden JW, Josleyn M. Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates. PLoS One. 2012;7(7):e42353.
- Edghill-Smith Y, Golding H, Manischewitz J, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med. 2005;11(7):740–747.
- Organization WH. Monkeypox. Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox
- Ahmed SF, Sohail MS. Vaccinia-virus-based vaccines are expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus. Viruses. 2022;14:9.
- Yang L, Chen Y, Li S, et al. Immunization of mice with vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus. Virol Sin. 2023 Feb;38(1):162–164.
- Zaeck LM, Lamers MM, Verstrepen BE, et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med. 2023 Jan;29(1):270–278.
- Hammarlund E, Lewis MW, Carter SV. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11(9):1005–1011.
- Taub DD, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med. 2008;121(12):1058–1064.
- Russo AT, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021;19(3):331–344.
- Delaune D, Iseni F. Drug development against smallpox: present and future. Antimicrob Agents Chemother. 2020;64:4.
- Hutson CL, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere. 2021;6:1.
- Prichard MN, Kern ER. Antiviral activity of 4'-thioIDU and thymidine analogs against orthopoxviruses. Viruses. 2010;2(9):1968–1983.